Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr397.20 DKK
Change Today -2.80 / -0.70%
Volume 2.5M
As of 11:04 AM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ingelise Saunders Mph,BSc

Former Vice President of International Operations, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 30 board members in 6 different organizations across 12 different industries.

See Board Relationships
66--

Background*

Mrs. Ingelise Saunders, Mph, B.Sc. serves as the Chief Executive Officer of SLS Invest. Mrs. Saunders has been Chief Executive Officer of TD Vaccines A/S since November 2009 and serves as its President. She served as Chief Executive Officer of Action Pharma A/S since March 2010. She served as the Chief Executive Officer at Celltech Pharmaceuticals at Celltech Group Limited since March 2002. She served as Chief Executive Officer of UCB Pharma Limited. She served as Global ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Director
Chief Executive Officer and Director
Chief Executive Officer, President and Director
Member of the Board

Education*

Master's Degree
Københavns Universitet

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr397.20 DKK -2.80

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.